P-Wave Terminal Force V1 Is Associated with Left Ventricular Diastolic Function in Patients with No Significant Perfusion Abnormality.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
2022
Historique:
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 2 4 2022
Statut: ppublish

Résumé

P-wave terminal force in lead V1 (PTFV1) is a marker of increased left atrial (LA) overload. Whether PTFV1 is associated with left ventricular (LV) diastolic function remains undetermined. We tested the hypothesis that PTFV1 is associated with LV diastolic parameters derived from gated myocardial perfusion single-photon emission computed tomography (SPECT) in patients with no significant perfusion abnormalities.The study population included 158 patients with preserved ejection fraction and no significant perfusion abnormalities. The amplitude and duration of the P-wave negative phase in lead V1 were measured using an electrocardiogram, and PTFV1 was calculated. The peak filling rate (PFR) and one-third mean filling rate (1/3 MFR) were obtained as LV diastolic parameters using gated SPECT.PTFV1 showed a weak correlation with the LA volume index (r = 0.31; P < 0.001). Significant associations were observed between PTFV1 and PFR (r = -0.27; P < 0.001) and 1/3 MFR (r = -0.26; P = 0.001). A multivariate linear regression analysis showed that age (β = -0.26; P < 0.001), LV end-diastolic volume index (β = -0.27; P = 0.001), and PTFV1 (β = -0.15; P = 0.036) were significant factors associated with PFR. Moreover, male gender (β = -0.16; P = 0.041), LV mass index (β = -0.17; P = 0.046), and PTFV1 (β = -0.17; P = 0.022) were significant factors associated with the 1/3 MFR.PTFV1 is associated with LV diastolic function, as derived from gated SPECT in patients with no significant perfusion abnormalities.

Identifiants

pubmed: 35354750
doi: 10.1536/ihj.21-712
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-305

Auteurs

Yukihiro Fukuda (Y)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Kazuhiro Nitta (K)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Yuichi Morita (Y)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Tasuku Higashihara (T)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Atsushi Takeda (A)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Takayuki Nakano (T)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Yoshiharu Sada (Y)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Noriaki Watanabe (N)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Hiroki Ikenaga (H)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Yukiko Nakano (Y)

Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH